Freeline, Checkmate make NASDAQ debuts as 2020 pads its record-setting IPO tally

Perceptive’s latest SPAC debuts, Tigermed begins trading

NASDAQ debuts by Syncona gene therapy company Freeline and Checkmate, a cancer company co-founded by Art Krieg, pushed the year’s IPO haul to $14.7 billion, more than double the amount raised over the same period in 2019.

The deals coincided with a third listing for a SPAC sponsored by Perceptive Advisors, as well as the first trading day

Read the full 580 word article

How to gain access

Continue reading with a
two-week free trial.